Recent studies suggested that BNP and NT-proBNP may have use in predicting stroke risk in patients with heart failure with preserved ejection fraction [42], prognostic potential for functional outcome after AIS [43,44], and use in optimizing the management of stroke associated to heart disease [45]. The gene discussed is NPPB; the disease is stroke disorder.